Compare MP & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MP | GMED |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 11.0B |
| IPO Year | 2020 | 2012 |
| Metric | MP | GMED |
|---|---|---|
| Price | $50.64 | $74.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | $75.25 | ★ $100.42 |
| AVG Volume (30 Days) | ★ 5.4M | 1.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.28 | ★ 422.67 |
| EPS | N/A | ★ 2.00 |
| Revenue | $331,952,000.00 | ★ $2,938,931,000.00 |
| Revenue This Year | $100.51 | $11.13 |
| Revenue Next Year | $60.41 | $6.28 |
| P/E Ratio | ★ N/A | $37.26 |
| Revenue Growth | ★ 147.15 | 16.65 |
| 52 Week Low | $37.81 | $54.17 |
| 52 Week High | $100.25 | $101.40 |
| Indicator | MP | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 43.52 | 29.02 |
| Support Level | $44.43 | N/A |
| Resistance Level | $62.90 | $87.55 |
| Average True Range (ATR) | 3.13 | 2.24 |
| MACD | -0.74 | -1.25 |
| Stochastic Oscillator | 2.20 | 7.17 |
MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.